Whole-Body Low Dose Irradiation Promotes the Efficacy of Conventional Radiotherapy for Cancer and Possible Mechanisms

Jin, S. Z.; Pan, X. N.; Wu, N.; Jin, G. H.; Liu, S. Z.
October 2007
Dose-Response;2007, Vol. 5 Issue 4, p349
Academic Journal
The purpose of the present study was to explore the possibility of establishing cancer radiotherapy protocols that could promote treatment efficacy at a reduced radiation dose. Mouse models of melanoma (B16) and Lewis lung carcinoma (LLC) were used in the experiments. Conventional local radiotherapy was combined with low dose whole-body irradiation (LDWBI) in the presence or absence of gene therapy by intratumor injection of a recombinant plasmid Egr-mIL-18-B7.1 (E18B). After a number of trials with different combinations it was found that a protocol of 2-week treatment with 2 x (E18B + 2 Gy + 0.075 Gy x 2) was found to be able to promote treatment efficacy at a reduced radiation dose. In this protocol local irradiation with 2Gy was administered 24h after intratumor injection of 10 �g of the plasmid E18B followed by LDWBI with 0.075 Gy every other day for 2 sessions in 1 week, and the procedure was repeated for another week. When this combined treatment was compared with conventional radiotherapy, i.e., 2Gy every other day 3 times in one week repeated for 2 weeks, the treatment efficacy was improved, as judged by increased average survival rate, reduced mean tumor weight, reduced pulmonary metastasis and suppressed intratumor capillary growth with a 2/3 reduction of radiation dose. Immunologic studies showed stimulated natural killer (NK) and cytotoxic T lymphocyte (CTL) activity as well as increased interferon-? (IFN-?) secretion in this combined treatment group as compared with the group receiving local treatment alone. It is suggested that up-regulation of host anticancer immunity by LDWBI and the initiation of expression of immune genes by both the local large dose and LDWBI are important factors in the realization of improved cancer control.


Related Articles

  • Incorporating breath holding and image guidance in the adjuvant gastric cancer radiotherapy: a dosimetric study. Weigang Hu; Jinsong Ye; Jiazhou Wang; Qing Xu; Zhen Zhang // Radiation Oncology;2012, Vol. 7 Issue 1, p98 

    Background: The respiratory related target motion and setup error will lead to a large margin in the gastric radiotherapy. The purpose of this study is to investigate the dosimetric benefit and the possibility of incorporating the breath-hold (BH) technique with online image-guided radiotherapy...

  • Combined Hyperthermia and Radiotherapy for the Treatment of Cancer. Kaur, Punit; Hurwitz, Mark D.; Krishnan, Sunil; Asea, Alexzander // Cancers;2011, Vol. 3 Issue 4, p3799 

    Radiotherapy is used to treat approximately 50% of all cancer patients, with varying success. Radiation therapy has become an integral part of modern treatment strategies for many types of cancer in recent decades, but is associated with a risk of long-term adverse effects. Of these side...

  • Retrovirally transduced murine T lymphocytes expressing FasL mediate effective killing of prostate cancer cells. Symes, J. C.; Siatskas, C.; Fowler, D. H.; Medin, J. A. // Cancer Gene Therapy;May2009, Vol. 16 Issue 5, p439 

    Adoptively transferred T cells possess anticancer activities partially mediated by T-cell FasL engagement of Fas tumor targets. However, antigen-induced T-cell activation and clonal expansion, which stimulates FasL activity, is often inefficient in tumors. As a gene therapy approach to overcome...

  • Enhanced radiosensitivity of non-small-cell lung cancer (NSCLC) by adenovirus-mediated ING4 gene therapy. Ling, C; Xie, Y; Zhao, D; Zhu, Y; Xiang, J; Yang, J // Cancer Gene Therapy;Oct2012, Vol. 19 Issue 10, p697 

    Radiotherapy is the common treatment of choice for locally advanced lung cancer, but the radioresistance of lung cancer remains a significant therapeutic obstacle. We previously demonstrated that adenovirus-mediated inhibitor of growth 4 (ING4) tumor suppressor gene delivery (AdVING4) can...

  • Hitchhiker's guide to the T cell. Rooney, Cliona M. // Nature Medicine;Oct2005, Vol. 11 Issue 10, p1051 

    Focuses on the use of tumor-targeted T cells and gene therapy. Delivery of a gene therapy vector to tumor cells; Benefits from antigen-specific T cells.

  • Circulating lymphocyte number has a positive association with tumor response in neoadjuvant chemoradiotherapy for advanced rectal cancer. Kitayama, Joji; Yasuda, Koji; Kawai, Kazushige; Sunami, Eiji; Nagawa, Hirokazu // Radiation Oncology;2010, Vol. 5, p47 

    Although neoadjuvant chemoradiotherapy (CRT) is the standard treatment for advanced rectal cancer (RC), markers to predict the treatment response have not been fully established. In 73 patients with advanced RC who underwent CRT in a neoadjuvant setting, we retrospectively examined the...

  • Use of palliative radiotherapy in brain and bone metastases (VARA II study). Exp�sito, Jose; Ja�n, Javier; Alonso, Enrique; Tovar, Isabel // Radiation Oncology;2012, Vol. 7 Issue 1, p131 

    Introduction: Metastases are detected in 20% of patients with solid tumours at diagnosis and a further 30% after diagnosis. Radiation therapy (RT) has proven effective in bone (BM) and brain (BrM) metastases. The objective of this study was to analyze the variability of RT utilization rates in...

  • Prophylactic cranial irradiation for patients with small-cell lung cancer. Bunn Jr., Paul A.; Kelly, Karen // JNCI: Journal of the National Cancer Institute;2/1/95, Vol. 87 Issue 3, p161 

    Editorial. Comments on prophylactic cranial irradiation for patients with small cell lung cancer. Histological differentiation between small cell lung cancer and non-small cell lung cancer; Reduction of central nervous system metastases rate with prophylactic irradiation; Stratification of...

  • Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. Arriagada, Rodrigo; Le Chevalier, Thierry // JNCI: Journal of the National Cancer Institute;2/1/95, Vol. 87 Issue 3, p183 

    Evaluates the effects of prophylactic cranial irradiation on brain metastasis, overall survival and late-occurring toxic effects in patients with small-cell lung cancer in complete remission. Decrease in risk of brain metastasis; Possible beneficial effect on overall survival; Trial design;...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics